Telix Pharmaceuticals Ltd
F:T3X
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Telix Pharmaceuticals Ltd
F:T3X
|
AU |
|
G
|
Grupo Financiero Multiva SAB de CV
BMV:GFMULTIO
|
MX |
|
C
|
Carrefour SA
OTC:CRERF
|
FR |
|
Amcor PLC
F:485B
|
UK |
|
Alma Metals Ltd
ASX:ALM
|
AU |
|
G50 Corp Ltd
OTC:GFTYF
|
AU |
|
C
|
City Steel PCL
SET:CITY
|
TH |
|
S
|
SSE PLC
XMUN:SCT
|
UK |
|
C
|
Cognex Corp
F:CGZ
|
US |
|
A
|
Advantest Corp
F:VAN
|
JP |
|
Wipro Ltd
NYSE:WIT
|
IN |
|
B
|
Beiersdorf AG
XMUN:BEI
|
DE |
|
NETGEAR Inc
NASDAQ:NTGR
|
US |
|
Aston Martin Lagonda Global Holdings PLC
F:A5SA
|
UK |
|
S
|
SEI Investments Co
XMUN:SI3
|
US |
|
Sun International Ltd
F:RY1B
|
ZA |
|
N
|
Nyocor Co Ltd
SSE:600821
|
CN |
|
Protalix Biotherapeutics Inc
F:PBDA
|
US |
|
M
|
Moderna Inc
F:0QF
|
US |
|
Hind Aluminium Industries Ltd
BSE:531979
|
IN |
Bankruptcy Probability
Telix Pharmaceuticals Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Telix Pharmaceuticals Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
5.3B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
450.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
206.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
179.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
80B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
54.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
46.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
43.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Telix Pharmaceuticals Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Telix Pharmaceuticals Ltd has total debt of 564.4m USD. This includes both short-term (0 USD) and long-term (564.4m USD) debt.
You can find a full breakdown on its Balance Sheet.
